Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?

Vereecken, Pierre; Heenen, Michel; Babar, Sajida; van Baren, Nicolas

doi:10.1111/j.1468-3083.2006.01853.x

Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?

Vereecken, Pierre

;

Heenen, Michel

;

Babar, Sajida

;

van Baren, Nicolas

(2007) Journal of the European Academy of Dermatology and Venereology — Vol. 21, n° 2, p. 278-280 (2007)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
144.45 KB

Request a copy

Details

Authors

Vereecken, Pierre
Author
Heenen, Michel
Author
Babar, Sajida
Author
van Baren, NicolasUCLouvain
Author

Affiliations

UCLouvainMD/MIGE - Département de microbiologie, d'immunologie et de génétique
UCLouvain(SLuc) Service d'hématologie

Citations

APA
Chicago
FWB

Vereecken, P., Heenen, M., Babar, S., & van Baren, N. (2007). Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients? Journal of the European Academy of Dermatology and Venereology, 21(2), 278-280. https://doi.org/10.1111/j.1468-3083.2006.01853.x (Original work published 2007)